DQ 65–79, A Peptide Derived from HLA Class II, Mimics p21 to Block T Cell Proliferation 1

DQ 65–79, a peptide derived from residues 65–79 of the α-chain HLA class II molecule DQA03011, blocks T cell proliferation and induces T cell apoptosis. Using a yeast two-hybrid assay, we previously identified proliferating cell nuclear Ag (PCNA) as an intracellular ligand for DQ 65–79. In this study, we show that three regions of PCNA, residues 81–100, 121–140, and 241–261, interact with DQ 65–79. Residues 241–261 of PCNA also interact with the C terminus (residues 139–160) of the cell cycle regulator, p21, suggesting that DQ 65–79 and p21 might function similarly. We show here that DQ 65–79 competitively inhibits binding of p21 to PCNA and that both DQ 65–79 and p21 139–160 induce T cell apoptosis, suggesting that DQ 65–79 and p21 act similarly to inhibit cell growth.

[1]  A. Krensky,et al.  DQ 65–79, a Peptide Derived from HLA Class II, Induces IκB Expression1 , 2002, The Journal of Immunology.

[2]  G. Dotto,et al.  p21(WAF1/Cip1): more than a break to the cell cycle? , 2000, Biochimica et biophysica acta.

[3]  Z. Jónsson,et al.  A Direct Interaction between Proliferating Cell Nuclear Antigen (PCNA) and Cdk2 Targets PCNA-interacting Proteins for Phosphorylation* , 2000, The Journal of Biological Chemistry.

[4]  B. Hoffman,et al.  Characterization of MyD118, Gadd45, and Proliferating Cell Nuclear Antigen (PCNA) Interacting Domains , 2000, The Journal of Biological Chemistry.

[5]  D. Lane,et al.  A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics. , 2000, Biochemistry.

[6]  A. Krensky,et al.  A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling. , 2000, The Journal of clinical investigation.

[7]  K. Ball,et al.  Reversible Phosphorylation at the C-terminal Regulatory Domain of p21Waf1/Cip1 Modulates Proliferating Cell Nuclear Antigen Binding* , 2000, The Journal of Biological Chemistry.

[8]  T. Tanaka,et al.  Intranuclear localization of proliferating cell nuclear antigen during the cell cycle in renal cell carcinoma. , 2000, Analytical and quantitative cytology and histology.

[9]  T. Tsurimoto PCNA binding proteins. , 1999, Frontiers in bioscience : a journal and virtual library.

[10]  R. Sikorski,et al.  A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells. , 1999, Cancer research.

[11]  V. Bohr,et al.  The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo. , 1999, Molecular biology of the cell.

[12]  A. Krensky,et al.  HLA-derived peptides as novel immunomodulatory therapeutics. , 1999, Journal of the American Society of Nephrology : JASN.

[13]  H. Snoeck,et al.  Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis. , 1999, The Journal of clinical investigation.

[14]  T. Tsurimoto PCNA, a multifunctional ring on DNA. , 1998, Biochimica et biophysica acta.

[15]  Z. Kelman,et al.  Protein-PCNA interactions: a DNA-scanning mechanism? , 1998, Trends in biochemical sciences.

[16]  A. Krensky,et al.  Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin. , 1998, Journal of immunology.

[17]  R. DePinho,et al.  Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Bernard Ducommun,et al.  p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells , 1998, Oncogene.

[19]  H. Ng,et al.  Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. , 1997, Science.

[20]  D. Lane,et al.  Homologous regions of Fen1 and p21Cip1 compete for binding to the same site on PCNA: a potential mechanism to co-ordinate DNA replication and repair , 1997, Oncogene.

[21]  M. Broggini,et al.  p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. , 1997, Cancer research.

[22]  Z. Kelman PCNA: structure, functions and interactions , 1997, Oncogene.

[23]  C. Smythe,et al.  Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1 , 1997, Current Biology.

[24]  W. Sellers,et al.  Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors , 1996, Molecular and cellular biology.

[25]  John Kuriyan,et al.  Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA , 1996, Cell.

[26]  Anindya Dutta,et al.  Cyclin-binding motifs are essential for the function of p21CIP1 , 1996, Molecular and cellular biology.

[27]  Anindya Dutta,et al.  A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo. , 1996, Nucleic acids research.

[28]  J. Hurwitz,et al.  Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21 (*) , 1995, The Journal of Biological Chemistry.

[29]  M. Nakanishi,et al.  The C-terminal Region of p21 Is Involved in Proliferating Cell Nuclear Antigen Binding but Does Not Appear to Be Required for Growth Inhibition (*) , 1995, The Journal of Biological Chemistry.

[30]  U. Hübscher,et al.  Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. , 1995, Biochemistry.

[31]  B. Ducommun,et al.  Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. , 1995, Oncogene.

[32]  M. Kirschner,et al.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA , 1995, Nature.

[33]  D. Lane,et al.  A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen , 1995, Current Biology.

[34]  M. Sayegh,et al.  Inhibition of the alloimmune response with synthetic nonpolymorphic class II MHC peptides. , 1995, Transplantation proceedings.

[35]  A. Nomura,et al.  Nuclear distribution of proliferating cell nuclear antigen (PCNA) in fertilized eggs of the starfish Asterina pectinifera. , 1994, Journal of cell science.

[36]  P. O'Connor,et al.  Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. , 1994, Science.

[37]  S. Elledge,et al.  Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Hannon,et al.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[39]  A. Krensky,et al.  Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. , 1994, Journal of immunology.

[40]  S. Matsuoka,et al.  D-type cyclin-binding regions of proliferating cell nuclear antigen. , 1994, The Journal of biological chemistry.

[41]  J. R. Smith,et al.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.

[42]  J. Fechner,et al.  Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. , 1994, Journal of immunology.

[43]  C. Turck,et al.  Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.

[44]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[45]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[46]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[47]  D. Beach,et al.  Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. , 1993, Molecular biology of the cell.

[48]  D. Shoskes,et al.  Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo. , 1993, Transplantation proceedings.

[49]  M. Mathews,et al.  Regulation of proliferating cell nuclear antigen during the cell cycle. , 1989, The Journal of biological chemistry.

[50]  R. Superina,et al.  Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes , 1988, Nature.

[51]  P. Parham,et al.  Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the α2 domain of HLA–A2 , 1987, Nature.

[52]  J. Strominger,et al.  Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D O Morgan,et al.  Cyclin-dependent kinases: engines, clocks, and microprocessors. , 1997, Annual review of cell and developmental biology.

[54]  A. Krensky,et al.  Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses. , 1993, Transplantation proceedings.

[55]  P. Parham,et al.  HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes , 1987, Nature.